Daejeon, South Korea

Ju Nam Kim

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Cj Cheiljedang Corporation, Korea Research Institute of Chemical Technology. Active years: 2018.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ju Nam Kim - Innovator in Homoserine-Based Compounds

Introduction

Ju Nam Kim is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of chemical technology, particularly in the treatment of homoserine-based compounds. His innovative approach has led to advancements that can benefit various industrial applications.

Latest Patents

Ju Nam Kim holds a patent titled "Process for treating homoserine-based compound." This patent relates to the preparation of a useful compound that serves as an intermediate for creating important industrial compounds. The process he developed allows for the mass production of useful compounds from homoserine-based materials in a simple and efficient manner.

Career Highlights

Throughout his career, Ju Nam Kim has worked with prominent organizations, including CJ CheilJedang Corporation and the Korea Research Institute of Chemical Technology. His experience in these institutions has allowed him to refine his expertise and contribute to significant advancements in chemical processes.

Collaborations

Ju Nam Kim has collaborated with esteemed colleagues such as Young Lyeol Yang and Byung Sik Kim. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Ju Nam Kim's work in the field of homoserine-based compounds exemplifies the impact of innovative thinking in chemical technology. His contributions continue to influence industrial applications and pave the way for future advancements.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…